Nexentis Technologies NXTS
NASDAQ NXTS
$1.44 +0.01 (+0.70%)
At close: Oct 2, 2026 · 4:00 PM EDT

Nexentis Technologies (NXTS) Return on Sales [ROS] (2019 - 2025)

Updated

Nexentis Technologies (NXTS) reported Return on Sales [ROS] of -66300.00% for Q3 2025, down 50344.44 percentage points from -15955.56% a year earlier and down 64031.02 percentage points from the prior quarter.

Analysis

Nexentis Technologies (NXTS) Return on Sales [ROS] (2019 - 2025) Analysis & Trends

Over the twelve months ended Sep 30, 2025, Nexentis Technologies' Return on Sales [ROS] came in at -2292.34%, up 740.52 percentage points year-over-year; for FY2024, it was -1563.33%, up 1318.04 percentage points from FY2023.

  • Return on Sales [ROS] has a five-year change of -464.90 percentage points (FY2019 to FY2024).
  • By year, Return on Sales [ROS] came in at -2881.37% in FY2023 (-1404.32 pp), -1477.05% in FY2022 (-403.51 pp), -1073.54% in FY2021 (-492.62 pp) and -580.93% in FY2020 (+517.51 pp).
  • The Q3 2025 figure ranks as the lowest quarterly Return on Sales [ROS] in data going back to Q1 2019.
  • Year over year, Return on Sales [ROS] gained in three of the last eight quarters, with an average year-over-year change of -7936.00 percentage points.
  • The high point for year-over-year Return on Sales [ROS] in five years was Q2 2025 (a gain of 2713.37 percentage points); the low point was Q3 2025 (a drop of 50344.44 percentage points).
  • Per Business Quant data, the three quarters before Q3 2025 came in at -2268.98% (Q2 2025), -937.88% (Q1 2025) and -155.32% (Q4 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 28.21%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 37.86%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -3.52%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 32.97%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 20.57%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 34.95%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -133.21%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 28.37%
10 Nexentis Technologies 1.18 Mn -21.59 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 -66,300.00%
Jun 30, 2025 -2,268.98%
Mar 31, 2025 -937.88%
Dec 31, 2024 -155.32%
Sep 30, 2024 -15,955.56%
Jun 30, 2024 -4,982.35%
Mar 31, 2024 -2,043.18%
Dec 31, 2023 -2,027.96%
Sep 30, 2023 -1,799.97%
Jun 30, 2023 -2,295.45%
Mar 31, 2023 -1,440.92%
Dec 31, 2022 -637.86%
Sep 30, 2022 -3,450.59%
Jun 30, 2022 -4,108.53%
Mar 31, 2022 -1,535.63%
Dec 31, 2021 -830.25%
Sep 30, 2021 -1,811.17%
Jun 30, 2021 -2,981.71%
Mar 31, 2021 -200.59%
Dec 31, 2020 -89.90%
API Access

Nexentis Technologies Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=NXTS&period=max&api_key=YOUR_API_KEY